51 research outputs found
The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug Trimethoprim
New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron
In a previous survey of 357 trimethoprim-resistant isolates of aerobic gram-negative bacteria from commensal fecal flora, hybridization experiments showed that 25% (90 of 357) of the isolates failed to hybridize to specific oligonucleotide probes for dihydrofolate reductase types 1, 2b, 3, 5, 6, 7, 8, 9, 10, and 12. Subsequent cloning and sequencing of a plasmid-borne trimethoprim resistance gene from one of these isolates revealed a new dihydrofolate reductase gene, dfr13, which occurred as a cassette integrated in a site-specific manner in a class 1 integron. The gene product shared 84% amino acid identity with dfr12 and exhibited a trimethoprim inhibition profile similar to that of dfr12. Gene probing experiments with an oligonucleotide probe specific for this gene showed that 12.3% (44 of 357) of the isolates which did not hybridize to probes for other dihydrofolate reductases hybridized to this probe. Immediately downstream of dfr13, a new cassette, an aminoglycoside resistance gene of the class AADA [ANT(3")(9)-I], which encodes streptomycin-spectinomycin resistance, was identified. This gene shares 57% identity with the consensus aadA1 (ant(3")-Ia) and has been called aadA4 (ant(3")-Id). The 3′ end of the aadA4 cassette was truncated by IS26, which was contiguous with a truncated form of Tn3. On the same plasmid, pUK2381, a second copy of IS26 was associated with sul2, which suggests that both integrase and transposase activities have played major roles in the arrangement and dissemination of antibiotic resistance genes dfr13, aadA4, bla(TEM-1), and sul2
Prevalence and genetic location of non-transferable trimethoprim resistant dihydrofolate reductase genes in South African commensal faecal isolates
Approximate random k-colouring of a graph G = (V, E) is a very well studied problem in computer science and statistical physics. It amounts to constructing a k-colouring of G which is distributed close to Gibbs distribution, i.e. the uniform distribution over all the k-colourings of G. Here, we deal with the problem when the underlying graph is an instance of Erdocombining double acute accents-Rényi random graph G(n, p), where p = d/n and d is fixed. We propose a novel efficient algorithm for approximate random k-colouring with the following properties: given an instance of G(n, d/n) and for any k ≥ (2 + ε)d, it returns a k-colouring distributed within total variation distance n -Ω(1) from the Gibbs distribution, with probability 1 - n -Ω(1). What we propose is neither a MCMC algorithm nor some algorithm inspired by the message passing heuristics that were introduced by statistical physicists. Our algorithm is of combinatorial nature. It is based on a rather simple recursion which reduces the random k-colouring of G(n, d/n) to random k-colouring simpler subgraphs first. The lower bound on the number of colours for our algorithm to run in polynomial time is significantly smaller than the corresponding bounds we have for any previous algorithm. Copyright © SIAM
Prevalence and genetic location of non-transferable trimethoprim resistant dihydrofolate reductase genes in South African commensal faecal isolates
The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial
Hip displacement is the second most common deformity after equinus in children with cerebral palsy (CP), and may result in dislocation, pain, fixed deformity and loss of function. We studied the combined effects of intramuscular injections of botulinum toxin type A (BTX-A) to the adductors and hamstrings and a variable hip abduction orthosis (SWASH). on gross motor function, hip displacement and progression to surgery, in a randomized clinical trial. Thirty-nine children, with bilateral spastic cerebral palsy, and mean age 3 years + 2 months (range 1 year + 7 months -4 years + 10 months) entered the trial. Gross Motor Function Classification System (GMFCS) levels were as follows: one child was level II, 11 were level III, 13 were level IV and 14 were level V. After concealed randomization. 20 were allocated to the control group and 19 to the intervention group. Thirty-five children completed the follow up at 1 year. The novel intervention group received up to 4.0 U BOTOX(R)/kg/ muscle, 16 U/kg/body weight every 6 months plus the use of a SWASH brace. The control group received clinical best practice comprising physiotherapy but no hip abduction bracing. Both groups showed improvements in total Gross Motor Function Measure (GMFM) score [mean 6.0% BTX-A group; 6.1% Control 95% CI - 6.7, 6.5 (NS)], however, there was no additional treatment effect for the study group. There were similar improvements on GMFM goal scores and GMFM-66 scores, but again no additional treatment effect was observed. Multiple regression of change in total GMFM by GMFCS classification for each group showed greater improvement in the total scores from baseline in the BTX-A/SWASH treated group than the control group. In the first year. nine children (two in the intervention group and seven in the control group) required soft tissue surgery because of progressive hip migration in excess of 40%. A longer-term follow up of a larger cohort may be required to determine the effect of the combined treatment on hip displacement
Inhibition of rat folic acid reductase activity by trimethoprim during the later stages of gestation
The Purification and Properties of the Trimethoprim-Resistant Dihydrofolate Reductase Mediated by the R-Factor, R 388
Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984
- …